saypha® lips

Lidocaine

saypha® lips Lidocaine¹

  • Indication

    The viscoelastic implant is indicated for lip augmentation.
  • Injection depth

    Submucosa

Ingredients

  • Concentration HA

    2.3 % (23 mg/mL)
    High molecular weight hyaluronic acid of non-animal origin

  • Crosslinking agent

    BDDE (concentration ≤ 2 ppm)

Packaging

  • Packaging unit

    1 box of 1 mL syringe

  • Needle

    2 x 27 G x 1/2" thin wall Terumo™ needle (CE 0197)

Questions?

Get in touch with a representative at our booth.

Related Products

¹ Instruction for Use (IFU)
The healthcare professional confirms having informed the consumer of a likely risk associated with the use of the device in line with its intended use. For risks and adverse events associated with the use of the device consult the instructions of use.​

Saypha: CE 0123